Jerzy Hubert
Psychiatry · Portland, ORNPI 1437563186
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.5% of the total across 174 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 17 manufacturers, the largest accounting for just 21.9% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2023 at $1,935 and has fallen 73.2% since, to $518 in 2024. Among psychiatry clinicians in OR with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 174 payments — averaging $18.32 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$699
- Alkermes, Inc.$430
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$301
- Takeda Pharmaceuticals U.S.A., Inc.$281
- Otsuka America Pharmaceutical, Inc.$259
- Axsome Therapeutics, Inc.$217
- plus $1K from 11 others
What the payments were for
- Food & beverage$3,13898%
- Education$492%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 48 | $699 |
| Alkermes, Inc. | 19 | $430 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 17 | $301 |
| Takeda Pharmaceuticals U.S.A., Inc. | 13 | $281 |
| Otsuka America Pharmaceutical, Inc. | 15 | $259 |
| Axsome Therapeutics, Inc. | 11 | $217 |
| Neurocrine Biosciences, Inc. | 11 | $186 |
| Lundbeck LLC | 7 | $148 |
| Corium, LLC | 6 | $136 |
| Ironshore Pharmaceuticals Inc. | 5 | $112 |
| Johnson & Johnson | 5 | $105 |
| Idorsia Pharmaceuticals US Inc | 5 | $80 |
| Bausch Health US, LLC | 4 | $66 |
| Supernus Pharmaceuticals, Inc. | 2 | $58 |
| Biogen | 2 | $41 |
| Teva Pharmaceuticals USA, Inc. | 2 | $40 |
| Tris Pharma Inc | 2 | $28 |
How this compares
$3,187 in reported general payments places this provider in the 95th percentile of 366 psychiatry providers in Oregon.
Other psychiatry in Portland
- Alisha MorelandPortland$20K
- Leigh Anne BresslerPortland$15K
- Alfred LewyPortland$9K
- Anca Maria BejenaruPortland$6K
- Shondell DiazPortland$3K
- Kara PrussingPortland$3K
- Lyle JobePortland$3K
- Jon MessingerPortland$1K
- Allegra CondiottePortland$1K
- Thomas MeyerPortland$913
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.